Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Brian Freed to Drug Synergism

This is a "connection" page, showing publications Brian Freed has written about Drug Synergism.

 
Connection Strength
 
 
 
0.052
 
  1. Geiselhart L, Conti DJ, Freed BM. RO 31-8220, a novel protein kinase C inhibitor, inhibits early and late T cell activation events. Transplantation. 1996 Jun 15; 61(11):1637-42.
    View in: PubMed
    Score: 0.033
  2. Freed BM, Stevens C, Zhang G, Rosano TG, Lempert N. A comparison of the effects of cyclosporine and steroids on human T lymphocyte responses. Transplant Proc. 1988 Apr; 20(2 Suppl 2):233-9.
    View in: PubMed
    Score: 0.019
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)